Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Full Year Trading Update

7 Apr 2025 07:00

RNS Number : 8418D
Volex PLC
07 April 2025
 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

7 April 2025

 

Volex plc

 

("Volex", the "Company" or the "Group")

Full Year Trading Update

Full year growth and profit ahead of market expectations

Volex (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today releases a trading update for the financial year ended 30 March 2025 ("FY2025").

Revenue growth and improved profitability driven by strong Q4 momentum

Following a strong fourth quarter, revenue for FY2025 is now expected to be at least $1,060 million, representing a year-on-year increase of at least 16%, and organic constant currency growth of at least 8%. Underlying operating margins are anticipated to be at the upper end of the target corridor of 9% to 10%, with operating profit of at least $100 million, well ahead of the top end of market estimates1.

This robust financial performance highlights Volex's ongoing success in securing new projects through delivering cost-competitive and technically advanced manufacturing services. 

Improved underlying operating profit margins in the second half were driven by a favourable product mix, including increased demand for data centre products, as well as a focus on incremental operational improvements.

Harnessing manufacturing technology to deliver organic growth

The significant organic growth achieved this year reflects the Group's strong market positions across a diverse range of specialist sectors, where Volex leverages deep technical expertise to meet complex customer requirements.

Our embedded presence in global technology supply chains continues to generate exciting opportunities and deliver consistent, high-quality solutions for customers, while the Group's focus on specialist markets with high customer lock-in and limited competition means that we are an essential and trusted partner to the global technology companies we work with.

Electric Vehicles (EV) and Consumer Electricals continued their strong momentum, securing several new key customer relationships, positioning the Group well for FY2026.

Complex Industrial Technology experienced notable strength, delivering low double-digit organic growth, supported by increased data centre product demand, particularly driven by accelerated infrastructure investments from a major customer in the last quarter of the year.

Medical sector revenues declined against a prior-year comparative period that benefitted from one-time customer catch-up orders.

Integration activity continues in the Group's Off-Highway business, delivering planned productivity improvements and efficiencies. Growth in this segment normalised during the year, with softer macroeconomic conditions in some end-markets offset by several strategic customer wins in North America and Europe, resulting in flat year-on-year organic revenue.

Strategic investment driven by customer demand

The Group continued to invest strategically in capacity expansion, automation, and vertical integration initiatives during the year, all closely aligned with servicing ever evolving customer needs. Additional capacity in key locations positions Volex for site consolidation opportunities in FY2026, supporting long-term operational efficiencies.

After targeted capex investment to support growth of approximately $45 million, covenant leverage3 at 30 March 2025 was approximately 1.1x, consistent with the prior-year.

Embedded customer relationships mitigate trade volatility

The breadth and rapid evolution of recent changes in international trade policies and market dynamics are unprecedented, making precise quantification of direct and indirect impacts challenging and increasing operational complexity.

However, Volex's strategic investments in geographic diversification and global manufacturing flexibility have created a highly resilient platform that is well-positioned to support customers navigating these dynamic market conditions.

Leveraging deep expertise and an agile global footprint, Volex proactively engages with customers to adapt production locations and mitigate potential disruptions effectively. Given the evolving tariff landscape, customers are cautious about making short-term supply chain decisions, further enhancing the value of Volex's embedded and critical roles supporting their procurement activities.

The majority of Volex's products represent essential components within complex supply chains. In many instances, Volex is either the sole provider or one of very few qualified manufacturers capable of meeting demanding technical and operational requirements, fostering strong customer reliance. Incremental costs arising from tariff changes are expected to be passed through to customers, underscoring the robustness of Volex's competitive positioning.

 

Nat Rothschild, Executive Chairman, said:

"We are delighted with another year of very significant progress at Volex, delivering a performance that has comfortably exceeded market expectations, clearly demonstrating the effectiveness of our strategy.

 

"For the first time in Volex's history, revenue and profits have exceeded $1 billion and $100 million respectively. This is a direct result of our continued investment in advanced manufacturing capabilities, coupled with our strategic focus on key growth sectors, whilst simultaneously maintaining strong returns on capital employed.

 

"Although wider market uncertainty has increased in recent days, particularly around tariffs, Volex's current market valuation fails to adequately reflect our embedded presence in global technology supply chains, alongside the unique geographic and end-market diversification that has become such a feature of the Volex that our team has built in recent years.

 

"I am very confident that these elements mean we are well placed to navigate prevailing market conditions and continue to deliver on the significant growth opportunities that lie ahead."

 

 

For further information please contact:

Volex plc+44 (0) 1256 442570
Nat Rothschild, Executive Chairmaninvestor.relations@volex.com
Jon Boaden, Chief Financial Officer

 

 

 

Peel Hunt LLP - Nominated Adviser & Joint Broker+44 (0) 20 7418 8900
Ed Allsopp

 

Dom Convey

 

Tom Graham

 

 

 

Jefferies - Joint Broker+44 (0) 20 7029 8000
Philip Noblet

 

Sam Barnett

 

Harry Le May

 

 

 

Sodali & Co - Media Enquiries+44 (0) 20 7250 1446
James White

 

Nicholas Johnson

 

 

  About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key sectors: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 27 advanced manufacturing facilities, uniting 14,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

 

Notes

1.  As at 2 April 2025, the average of company compiled analysts' forecasts for the 52 weeks ending 30 March 2025 for revenue is $1,032.6 million with a range of $1,027.7million to $1,040.0 million, the average for underlying operating profit is $96.7 million, with a range of $95.8 million to $97.6 million.

2.  Underlying operating profit is before adjusting items which are one-off in nature and significant (such as restructuring costs, impairment charges or acquisition-related costs), the amortisation and impairment of acquired intangible assets and share-based payment charges. This trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

3.  Covenant leverage is net debt (before operating lease liabilities) divided by underlying EBITDA adjusted for depreciation of right-of-use assets and pro-rated for acquisitions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSEFWMEISEDL
Date   Source Headline
7th Dec 20233:42 pmRNSScrip Reference Price
23rd Nov 20237:00 amRNSHalf-year report
8th Nov 20237:15 amRNSAnalyst Briefing & Investor Presentation
24th Oct 20237:00 amRNSUpdate on H1 Trading and Cyber Incident
20th Oct 20237:00 amRNSDirectorate Changes
9th Oct 20237:00 amRNSNotice of Cyber Incident
28th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSCompletion of Murat Ticaret Acquisition
30th Aug 20235:00 pmRNSDirector/PDMR Shareholding
21st Aug 20234:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20237:00 amRNSReceipt of Competition Clearance for Murat Ticaret
27th Jul 20236:23 pmRNSResult of AGM
27th Jul 202311:37 amRNSScrip Reference Price
27th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20234:40 pmRNSDirector/PDMR Shareholding
28th Jun 20234:59 pmRNSHolding(s) in Company
27th Jun 202310:00 amRNSNotice of AGM and Publication of Annual Report
22nd Jun 20231:00 pmRNSResults of Fundraising
22nd Jun 20237:02 amRNSREX Retail Offer
22nd Jun 20237:01 amRNSAcquisition of Murat Ticaret and Proposed Placing
22nd Jun 20237:00 amRNSPreliminary Group Results FY2023
12th Jun 20237:00 amRNSNotice of Results and Investor Presentation
18th May 20237:00 amRNSChange of Adviser
27th Apr 20237:00 amRNSEV Contract Win
18th Apr 20237:00 amRNSFull Year Trading Update
18th Jan 20237:00 amRNSAnalyst Site Visit
22nd Dec 202210:03 amRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20227:00 amRNSScrip Reference Price
9th Nov 20227:00 amRNSHalf-year Report of Volex plc
13th Oct 20227:00 amRNSNotice of Half Year Results
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20223:58 pmRNSDirector / PDMR Dealing
30th Aug 20223:36 pmRNSDirector / PDMR Dealing
19th Aug 20225:32 pmRNSResults of AGM, Issue of Equity and TVR
19th Aug 20227:00 amRNSAGM Statement
29th Jul 20224:00 pmRNSScrip Dividend Scheme and Scrip Reference Price
11th Jul 202210:53 amRNSNotice of AGM and Publication of Annual Report
29th Jun 20225:08 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSPreliminary Group Results FY2022
8th Jun 20227:00 amRNSNotice of Preliminary Results & IMC Presentation
19th May 20227:00 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSCompletion of inYantra acquisition
20th Apr 20227:00 amRNSTrading Update
12th Apr 202212:38 pmRNSHolding(s) in Company
6th Apr 202210:42 amRNSHolding(s) in Company
15th Mar 202211:14 amRNSPDMR / PCA Dealing
8th Mar 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.